Technical Analysis for LNTH - Lantheus Holdings, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 56.52 | -2.84% | -1.65 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Fell Below 50 DMA | Bearish | -2.84% | |
Multiple of Ten Bearish | Other | -2.84% | |
Outside Day | Range Expansion | -2.84% | |
Oversold Stochastic | Weakness | -2.84% | |
NR7 | Range Contraction | -5.53% | |
Multiple of Ten Bearish | Other | -5.53% |
Alert | Time |
---|---|
Down 2 % | about 14 hours ago |
60 Minute Opening Range Breakdown | about 14 hours ago |
Possible NR7 | about 15 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
Down 1% | about 20 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/02/2024
Lantheus Holdings, Inc. Description
Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Disease Chemical Elements Prostate Cancer Heart Failure Medical Imaging Stroke Medical Physics Perfusion Artery Radiopharmaceuticals Artery Disease Congestive Heart Failure Imaging Agent Peripheral Vascular Disease Coronary Artery Disease Gallium Neuron Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 100.8505 |
52 Week Low | 50.2 |
Average Volume | 1,183,897 |
200-Day Moving Average | 69.16 |
50-Day Moving Average | 58.47 |
20-Day Moving Average | 62.57 |
10-Day Moving Average | 60.93 |
Average True Range | 2.31 |
RSI (14) | 37.11 |
ADX | 20.02 |
+DI | 19.66 |
-DI | 29.35 |
Chandelier Exit (Long, 3 ATRs) | 62.79 |
Chandelier Exit (Short, 3 ATRs) | 63.00 |
Upper Bollinger Bands | 69.73 |
Lower Bollinger Band | 55.40 |
Percent B (%b) | 0.08 |
BandWidth | 22.91 |
MACD Line | -0.08 |
MACD Signal Line | 0.89 |
MACD Histogram | -0.9763 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 59.81 | ||||
Resistance 3 (R3) | 60.14 | 59.39 | 59.26 | ||
Resistance 2 (R2) | 59.39 | 58.55 | 59.22 | 59.07 | |
Resistance 1 (R1) | 57.95 | 58.03 | 57.58 | 57.62 | 58.89 |
Pivot Point | 57.20 | 57.20 | 57.01 | 57.03 | 57.20 |
Support 1 (S1) | 55.76 | 56.36 | 55.39 | 55.43 | 54.15 |
Support 2 (S2) | 55.01 | 55.84 | 54.84 | 53.97 | |
Support 3 (S3) | 53.57 | 55.01 | 53.78 | ||
Support 4 (S4) | 53.24 |